{"id":66018,"date":"2021-08-11T08:57:27","date_gmt":"2021-08-11T06:57:27","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/"},"modified":"2025-10-13T15:32:10","modified_gmt":"2025-10-13T13:32:10","slug":"la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/","title":{"rendered":"La AEMPS autoriza el ensayo cl\u00ednico fase I\/IIa de la vacuna HIPRA Covid-19"},"content":{"rendered":"<p><strong>La farmac\u00e9utica <a href=\"https:\/\/www.hipra.com\/portal\/es\/hipra\/home\" target=\"_blank\" rel=\"noopener\">Hipra<\/a>, con sede en Amer (Girona), ha recibido la autorizaci\u00f3n por parte de la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) del ensayo cl\u00ednico fase I\/IIa de la vacuna HIPRA Covid-19. Se trata del primer ensayo en humanos de una vacuna contra el SARS-CoV-2 desarrollada en Espa\u00f1a. El equipo que la multinacional tiene en su <a href=\"https:\/\/www.pcb.ub.edu\/es\/empresa\/hipra-scientific\/\" target=\"_blank\" rel=\"noopener noreferrer\">centro de I+D en el Parc Cient\u00edfic de Barcelona<\/a>\u00a0-donde se lleva a cabo una parte de la investigaci\u00f3n necesaria para el dise\u00f1o, generaci\u00f3n y caracterizaci\u00f3n de nuevos ant\u00edgenos vacunales- est\u00e1 participando activamente en el proyecto.<\/strong><\/p>\n<p>Est\u00e1 previsto que los ensayos empiecen a mediados de agosto en el Hospital Cl\u00ednic de Barcelona y en el Hospital Josep Trueta de Girona con un grupo voluntarios de entre 18 y 39 a\u00f1os, que no han recibido la vacuna contra la Covid-19 y no han pasado la infecci\u00f3n. Su objetivo principal es evaluar la seguridad y la tolerabilidad de la vacuna. Adicionalmente, se evaluar\u00e1n su inmunogenicidad y eficacia.<\/p>\n<p>La vacuna HIPRA Covid-19, que desarrolla Hipra, es una vacuna de prote\u00edna recombinante que ha sido dise\u00f1ada para optimizar su seguridad y conseguir una potente respuesta inmunitaria neutralizadora del virus de la Covid-19. Se conservar\u00e1 entre 2 y 8\u00baC, hecho que facilitar\u00e1 la log\u00edstica y la distribuci\u00f3n.<\/p>\n<p>La previsi\u00f3n es que la producci\u00f3n de la vacuna HIPRA Covid-19 empiece en octubre en las instalaciones de Hipra con el objetivo de empezar la comercializaci\u00f3n a principios del 2022, sujeto a la obtenci\u00f3n de las autorizaciones oportunas.<\/p>\n<p><strong>\u00bb\u00a0<a href=\"https:\/\/www.pcb.ub.edu\/es\/hipra-preve-producir-400-millones-de-dosis-de-su-vacuna-hipra-sars-cov-2-durante-el-2022\/\" target=\"_blank\" rel=\"noopener\">Noticia relacionada [+]<\/a><\/strong><br \/>\n<strong>\u00bb M\u00e1s informaci\u00f3n: <a href=\"https:\/\/www.hipracovid19.com\/vacuna-covid19\/\" target=\"_blank\" rel=\"noopener\">web de Hipra [+]<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La farmac\u00e9utica Hipra, con sede en Amer (Girona), ha recibido la autorizaci\u00f3n por parte de la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) del ensayo cl\u00ednico fase I\/IIa de&#8230;<\/p>\n","protected":false},"author":4,"featured_media":66003,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[356],"tags":[],"class_list":["post-66018","post","type-post","status-publish","format-standard","has-post-thumbnail","category-empresas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La AEMPS autoriza el ensayo cl\u00ednico fase I\/IIa de la vacuna HIPRA Covid-19 - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La AEMPS autoriza el ensayo cl\u00ednico fase I\/IIa de la vacuna HIPRA Covid-19 - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"La farmac\u00e9utica Hipra, con sede en Amer (Girona), ha recibido la autorizaci\u00f3n por parte de la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) del ensayo cl\u00ednico fase I\/IIa de...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-11T06:57:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:32:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/08\/tecnics-treballant-amb-cromatografs_HIPRA.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Azucena Berea\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Azucena Berea\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/\"},\"author\":{\"name\":\"Azucena Berea\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/810a86a39effe6bf90f9ab918ca43239\"},\"headline\":\"La AEMPS autoriza el ensayo cl\u00ednico fase I\\\/IIa de la vacuna HIPRA Covid-19\",\"datePublished\":\"2021-08-11T06:57:27+00:00\",\"dateModified\":\"2025-10-13T13:32:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/\"},\"wordCount\":293,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/tecnics-treballant-amb-cromatografs_HIPRA.png\",\"articleSection\":[\"EMPRESAS\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/\",\"name\":\"La AEMPS autoriza el ensayo cl\u00ednico fase I\\\/IIa de la vacuna HIPRA Covid-19 - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/tecnics-treballant-amb-cromatografs_HIPRA.png\",\"datePublished\":\"2021-08-11T06:57:27+00:00\",\"dateModified\":\"2025-10-13T13:32:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/810a86a39effe6bf90f9ab918ca43239\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/tecnics-treballant-amb-cromatografs_HIPRA.png\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/tecnics-treballant-amb-cromatografs_HIPRA.png\",\"width\":900,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La AEMPS autoriza el ensayo cl\u00ednico fase I\\\/IIa de la vacuna HIPRA Covid-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/810a86a39effe6bf90f9ab918ca43239\",\"name\":\"Azucena Berea\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g\",\"caption\":\"Azucena Berea\"},\"sameAs\":[\"https:\\\/\\\/www.pcb.ub.edu\"],\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/aberea\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La AEMPS autoriza el ensayo cl\u00ednico fase I\/IIa de la vacuna HIPRA Covid-19 - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/","og_locale":"es_ES","og_type":"article","og_title":"La AEMPS autoriza el ensayo cl\u00ednico fase I\/IIa de la vacuna HIPRA Covid-19 - Parc Cient\u00edfic de Barcelona","og_description":"La farmac\u00e9utica Hipra, con sede en Amer (Girona), ha recibido la autorizaci\u00f3n por parte de la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) del ensayo cl\u00ednico fase I\/IIa de...","og_url":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2021-08-11T06:57:27+00:00","article_modified_time":"2025-10-13T13:32:10+00:00","og_image":[{"width":900,"height":330,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/08\/tecnics-treballant-amb-cromatografs_HIPRA.png","type":"image\/png"}],"author":"Azucena Berea","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Azucena Berea","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/"},"author":{"name":"Azucena Berea","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/810a86a39effe6bf90f9ab918ca43239"},"headline":"La AEMPS autoriza el ensayo cl\u00ednico fase I\/IIa de la vacuna HIPRA Covid-19","datePublished":"2021-08-11T06:57:27+00:00","dateModified":"2025-10-13T13:32:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/"},"wordCount":293,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/08\/tecnics-treballant-amb-cromatografs_HIPRA.png","articleSection":["EMPRESAS"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/","url":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/","name":"La AEMPS autoriza el ensayo cl\u00ednico fase I\/IIa de la vacuna HIPRA Covid-19 - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/08\/tecnics-treballant-amb-cromatografs_HIPRA.png","datePublished":"2021-08-11T06:57:27+00:00","dateModified":"2025-10-13T13:32:10+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/810a86a39effe6bf90f9ab918ca43239"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/08\/tecnics-treballant-amb-cromatografs_HIPRA.png","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/08\/tecnics-treballant-amb-cromatografs_HIPRA.png","width":900,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/la-aemps-autoriza-el-ensayo-clinico-fase-i-iia-de-la-vacuna-hipra-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"La AEMPS autoriza el ensayo cl\u00ednico fase I\/IIa de la vacuna HIPRA Covid-19"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/810a86a39effe6bf90f9ab918ca43239","name":"Azucena Berea","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g","caption":"Azucena Berea"},"sameAs":["https:\/\/www.pcb.ub.edu"],"url":"https:\/\/www.pcb.ub.edu\/es\/author\/aberea\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/66018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=66018"}],"version-history":[{"count":4,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/66018\/revisions"}],"predecessor-version":[{"id":66023,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/66018\/revisions\/66023"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/66003"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=66018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=66018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=66018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}